11321154falsepharmacy2023-04-012024-03-31http://www.companieshouse.gov.uk/2023-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2023-03-31http://www.companieshouse.gov.uk/cd:Director12023-04-012024-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-03-31http://www.companieshouse.gov.uk/cd:Director22023-04-012024-03-31http://www.companieshouse.gov.uk/cd:OrdinaryShareClass12023-04-012024-03-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2023-04-012024-03-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2023-04-012024-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-03-31http://www.companieshouse.gov.uk/2023-04-012024-03-31http://www.companieshouse.gov.uk/2023-03-31http://www.companieshouse.gov.uk/cd:FRS1022023-04-012024-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/cd:FullAccounts2023-04-012024-03-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2023-04-012024-03-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 11321154

Lakepharm Ltd

ACCOUNTS
FOR THE YEAR ENDED 31/03/2024

Prepared By:
Berry Kearsley Stockwell Ltd
Accountants
Sterling House
31-32 High Street
Wellingborough
Northants
NN8 4HL

Lakepharm Ltd

ACCOUNTS
FOR THE YEAR ENDED 31/03/2024
DIRECTORS
Mr K C Chan
Mr H Patel
REGISTERED OFFICE
9 Fen View Court
Cambridge
Cambridgeshire
CB4 1RF
COMPANY DETAILS
Private company limited by shares registered in EW - England and Wales, registered number 11321154
ACCOUNTANTS
Berry Kearsley Stockwell Ltd
Accountants
Sterling House
31-32 High Street
Wellingborough
Northants
NN8 4HL

Lakepharm Ltd

ACCOUNTS
FOR THEYEARENDED31/03/2024
CONTENTS
Page
Directors' Report-
Accountants' Report-
Statement Of Comprehensive Income-
Balance Sheet3
Notes To The Accounts4
The following do not form part of the statutory financial statements:
Trading And Profit And Loss Account-
Profit And Loss Account Summaries-

Lakepharm Ltd

BALANCE SHEET AT 31/03/2024
20242023
Notes££
FIXED ASSETS
CURRENT ASSETS
Stock36,25536,724
Debtors599,06286,121
Cash at bank and in hand494,666454,046
629,983576,891
CREDITORS: Amounts falling due within one year6141,305142,950
NET CURRENT ASSETS488,678433,941
TOTAL ASSETS LESS CURRENT LIABILITIES488,678433,941
CAPITAL AND RESERVES
Called up share capital7100100
Profit and loss account488,578433,841
SHAREHOLDERS' FUNDS488,678433,941
For the year ending 31/03/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on 07/10/2024 and signed on their behalf by
.............................
Mr K C Chan
Director
.............................
Mr H Patel
Director

Lakepharm Ltd

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31/03/2024
1. ACCOUNTING POLICIES
1a. Basis Of Accounting
The accounts have been prepared under the historical cost convention.
The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006 .
1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Equipmentstraight line 33%
1c. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell (net realisable value). Costs, which comprise direct production costs, are based on the method most appropriate to the type of inventory class, but usually on a first-in-first-out basis. Overheads are charged to profit or loss as incurred. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
When stocks are sold, the carrying amount of those stocks is recognised as an expense in the period in which the related revenue is recognised. The amount of any write-down of stocks to net realisable value and all losses of stocks are recognised as an expense in the period in which the write-down or loss occurs. The amount of any reversal of any write-down of stocks is recognised as a reduction in the amount of stocks recognised as an expense in the period in which the reversal occurs.
1d. Pension Costs
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.
2. EMPLOYEES
20242023
No.No.
Average number of employees77

Lakepharm Ltd

3. TANGIBLE FIXED ASSETS
Cost
At 31/03/2024
Depreciation
At 31/03/2024
Net Book Amounts
At 31/03/2024
4. STOCK 20242023
££
Stock comprises:
Stock36,25536,724
36,25536,724
5. DEBTORS 20242023
££
Amounts falling due within one year
Trade debtors69,03761,201
VAT28,60122,617
Intercompany loans1161,052
Prepayments1,3081,251
99,06286,121
6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20242023
££
UK corporation tax38,37626,689
PAYE control2,9022,437
Salaries and wages control8,6207,422
Directors current account206206
Directors current account206206
Trade creditors89,444104,559
Pension schemes472340
Accruals1,0791,091
141,305142,950

Lakepharm Ltd

7. SHARE CAPITAL 20242023
££
Allotted, issued and fully paid:
100 Ordinary shares of £1 each100100
100100
8. CONTROLLING PARTY
The company is a wholly owned subsidiary of Lakeproppharm Ltd. Lakeproppharm Ltd is the ultimate parent company.